|
7751 |
Strategic Trial Designs To Avoid Pitfalls, Interpreting and Reducing High Placebo Rates, Era of More Stringent Trial Endpoints (e.g.: HiSCR 50 → HiSCR75/90/100, NRS 0/1)
Enthalten in Current dermatology reports Bd. 14, 21.11.2025, Nr. 1, date:12.2025: 1-14
|
|
|
|
7752 |
Stratification, Blinding and Placebo Effect in a Randomized, Double Blind Placebo-controlled Clinical Trial of Gold Bead Implantation in Dogs with Hip Dysplasia
Enthalten in Acta veterinaria Scandinavica Bd. 46, 30.6.2005, Nr. 2, date:6.2005: 1-12
|
|
|
|
7753 |
StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Enthalten in Trials Bd. 26, 11.7.2025, Nr. 1, date:12.2025: 1-15
|
|
|
|
7754 |
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Enthalten in Trials Bd. 25, 15.10.2024, Nr. 1, date:12.2024: 1-18
|
|
|
|
7755 |
Streckbrief PIONEER-1-Studie
Enthalten in Info Diabetologie Bd. 12, 8.9.2018, Nr. 4, date:9.2018: 50
|
|
|
|
7756 |
Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals
Enthalten in BMC medical ethics Bd. 15, 23.10.2014, Nr. 1, date:12.2014: 1-10
|
|
|
|
7757 |
Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients—protocol for a systematic review with meta-analysis and trial sequential analysis
Enthalten in Systematic Reviews Bd. 6, 24.6.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
7758 |
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial
Enthalten in Trials Bd. 17, 19.4.2016, Nr. 1, date:12.2016: 1-18
|
|
|
|
7759 |
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
Enthalten in BMC pregnancy and childbirth Bd. 17, 28.12.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
7760 |
Studie zur Therapie beim metastasierten kastrationsresistenten Prostatakarzinom (VIABLE)
Enthalten in Forum Bd. 31, 29.1.2016, Nr. 1, date:2.2016: 63-64
|
|
Administration
